Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans-Theodor Eich

Showing results (1-10 of 238) with videos related to

Pageof 24
Sort By:
Deutsches Arzteblatt International|July 4, 2018
Some Necessary Additional PointsMichael Oertel, Hans-Theodor Eich
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 27, 2021
[Bridging before CAR T-cell therapy-a new opportunity for radiotherapy?]Michael Oertel, Hans Theodor Eich
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 30, 2024
[Improved prognosis with radiotherapy in early-stage Hodgkin lymphoma: a critical analysis of the long-term data from the EORTC/LYSA/FIL H10 trial]Michael Oertel, Hans Theodor Eich
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 19, 2016
[No general recommendation for waiving consolidated radiotherapy in Hodgkin lymphoma and negative PET results after completion of chemotherapy]Jan Kriz, Hans Theodor Eich
International Journal of Radiation Oncology, Biology, Physics|May 13, 2023
In Regard to Campbell et alMichael Oertel, Hans Theodor Eich
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 27, 2014
[Low-dose chemotherapy is highly effective in adults with sporadic or HIV-associated Burkitt's lymphoma]Gabriele Reinartz, Hans Theodor Eich
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 3, 2025
[Came to stay? Nivolumab in first-line treatment of advanced stage Hodgkin's lymphoma-A radiotherapeutic afterthought of the SWOG S1826 study]Michael Oertel, Hans Theodor Eich
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 14, 2023
[Is radiotherapy for diffuse large B-cell lymphoma obsolete? : A radio-oncological view on the UNFOLDER study]Michael Oertel, Hans Theodor Eich
Der Gynakologe|May 2, 2022
[Radiotherapy for the treatment of leukemia]Michael Oertel, Hans Theodor Eich
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 14, 2020
Risk stratification of pulmonary toxicities in the combination of whole lung irradiation and high-dose chemotherapy for Ewing sarcoma patients with lung metastases: a reviewSergiu Scobioala, Hans Theodor Eich
Pageof 24

Showing results (1-10 of 238) with videos related to

Sort By:
Pageof 24
Deutsches Arzteblatt International|July 4, 2018
Some Necessary Additional PointsMichael Oertel, Hans-Theodor Eich
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 27, 2021
[Bridging before CAR T-cell therapy-a new opportunity for radiotherapy?]Michael Oertel, Hans Theodor Eich
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 30, 2024
[Improved prognosis with radiotherapy in early-stage Hodgkin lymphoma: a critical analysis of the long-term data from the EORTC/LYSA/FIL H10 trial]Michael Oertel, Hans Theodor Eich
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 19, 2016
[No general recommendation for waiving consolidated radiotherapy in Hodgkin lymphoma and negative PET results after completion of chemotherapy]Jan Kriz, Hans Theodor Eich
International Journal of Radiation Oncology, Biology, Physics|May 13, 2023
In Regard to Campbell et alMichael Oertel, Hans Theodor Eich
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 27, 2014
[Low-dose chemotherapy is highly effective in adults with sporadic or HIV-associated Burkitt's lymphoma]Gabriele Reinartz, Hans Theodor Eich
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 3, 2025
[Came to stay? Nivolumab in first-line treatment of advanced stage Hodgkin's lymphoma-A radiotherapeutic afterthought of the SWOG S1826 study]Michael Oertel, Hans Theodor Eich
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 14, 2023
[Is radiotherapy for diffuse large B-cell lymphoma obsolete? : A radio-oncological view on the UNFOLDER study]Michael Oertel, Hans Theodor Eich
Der Gynakologe|May 2, 2022
[Radiotherapy for the treatment of leukemia]Michael Oertel, Hans Theodor Eich
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 14, 2020
Risk stratification of pulmonary toxicities in the combination of whole lung irradiation and high-dose chemotherapy for Ewing sarcoma patients with lung metastases: a reviewSergiu Scobioala, Hans Theodor Eich
Pageof 24